Table of Contents
Journal of Allergy
Volume 2013, Article ID 627384, 8 pages
http://dx.doi.org/10.1155/2013/627384
Review Article

Insulin and the Lung: Connecting Asthma and Metabolic Syndrome

1Center of Excellence for Translational Research in Asthma & Lung Disease, CSIR-Institute of Genomics and Integrative Biology, New Delhi 110007, India
2Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA
3Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA
4Research Center for Prevention and Health, Glostrup University Hospital, Glostrup 2600, Denmark

Received 23 March 2013; Revised 8 August 2013; Accepted 21 August 2013

Academic Editor: Balaram Ghosh

Copyright © 2013 Suchita Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Demoly, B. Gueron, K. Annunziata, L. Adamek, and R. D. Walters, “Update on asthma control in five European countries: results of a 2008 survey,” European Respiratory Review, vol. 19, no. 116, pp. 150–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Gershon, C. Wang, J. Guan, and T. To, “Burden of comorbidity in individuals with asthma,” Thorax, vol. 65, no. 7, pp. 612–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Beuther and E. R. Sutherland, “Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 7, pp. 661–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. B. H. Thuesen, L. L. N. Husemoen, L.-G. Hersoug, C. Pisinger, and A. Linneberg, “Insulin resistance as a predictor of incident asthma-like symptoms in adults,” Clinical and Experimental Allergy, vol. 39, no. 5, pp. 700–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. O. O. Adeyeye, A. O. Ogbera, O. O. Ogunleye et al., “Understanding asthma and the metabolic syndrome—a Nigerian report,” International Archives of Medicine, vol. 5, no. 1, article 20, 2012. View at Google Scholar
  6. B. M. Brumpton, C. A. Camargo Jr, P. R. Romundstad, A. Langhammer, Y. Chen, and X. M. Mai, “Metabolic syndrome and incidence of asthma in adults: the HUNT study,” European Respiratory Journal, 2013. View at Google Scholar
  7. J. Park, T. B. Kim, H. Joo, J. S. Lee, S. D. Lee, and Y. M. Oh, “Diseases concomitant with asthma in middle-aged and elderly subjects in Korea: a population-based study,” Allergy, Asthma & Immunology Research, vol. 5, no. 1, pp. 16–25, 2013. View at Google Scholar
  8. M. Canöz, F. Erdenen, H. Uzun, C. Müderrisoǧlu, and S. Aydin, “The relationship of inflammatory cytokines with asthma and obesity,” Clinical and Investigative Medicine, vol. 31, no. 6, pp. E373–E379, 2008. View at Google Scholar · View at Scopus
  9. D. A. Beuther, S. T. Weiss, and E. R. Sutherland, “Obesity and asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 2, pp. 112–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Haldar, I. D. Pavord, D. E. Shaw et al., “Cluster analysis and clinical asthma phenotypes,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 3, pp. 218–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. L. N. Husemoen, C. Glümer, C. Lau, C. Pisinger, L. S. Mørch, and A. Linneberg, “Association of obesity and insulin resistance with asthma and aeroallergen sensitization,” Allergy, vol. 63, no. 5, pp. 575–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. DeFronzo and E. Ferrannini, “Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease,” Diabetes Care, vol. 14, no. 3, pp. 173–194, 1991. View at Google Scholar · View at Scopus
  13. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Uzunlulu, A. Oguz, C. Gedik, G. Aslan, and S. Arik, “Is prevalence of metabolic syndrome high in patients with asthma?” Acta Clinica Belgica, vol. 66, no. 1, pp. 49–52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. E. Akpinar, S. Akpinar, S. Ertek, E. Sayin, and M. Gulhan, “Systemic inflammation and metabolic syndrome in stable COPD patients,” Tüberküloz ve Toraks, vol. 60, no. 3, pp. 230–237, 2012. View at Google Scholar
  16. J.-P. Després, I. Lemieux, J. Bergeron et al., “Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1039–1049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Agrawal, U. Mabalirajan, T. Ahmad, and B. Ghosh, “Emerging interface between metabolic syndrome and asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 3, pp. 270–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Sonksen and J. Sonksen, “Insulin: understanding its action in health and disease,” British Journal of Anaesthesia, vol. 85, no. 1, pp. 69–79, 2000. View at Google Scholar · View at Scopus
  19. E. J. Gallagher and D. LeRoith, “Minireview: IGF, insulin, and cancer,” Endocrinology, vol. 152, no. 7, pp. 2546–2551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Rosenfeld, “Insulin: discovery and controversy,” Clinical Chemistry, vol. 48, no. 12, pp. 2270–2288, 2002. View at Google Scholar · View at Scopus
  21. R. Aikawa, M. Nawano, Y. Gu et al., “Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 Kinase/Akt,” Circulation, vol. 102, no. 23, pp. 2873–2879, 2000. View at Google Scholar · View at Scopus
  22. R. J. Barth, “Insulin resistance, obesity and the metabolic syndrome,” South Dakota Medicine, no. 22–27, 2011. View at Google Scholar · View at Scopus
  23. M. Wozniak, B. Rydzewski, S. P. Baker, and M. K. Raizada, “The cellular and physiological actions of insulin in the central nervous system,” Neurochemistry International, vol. 22, no. 1, pp. 1–10, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Bugianesi, S. Moscatiello, M. F. Ciaravella, and G. Marchesini, “Insulin resistance in nonalcoholic fatty liver disease,” Current Pharmaceutical Design, vol. 16, no. 17, pp. 1941–1951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Grundy, “Obesity, metabolic syndrome, and cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2595–2600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Ferrannini, A. Natali, B. Capaldo, M. Lehtovirta, S. Jacob, and H. Yki-Järvinen, “Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR),” Hypertension, vol. 30, no. 5, pp. 1144–1149, 1997. View at Google Scholar · View at Scopus
  27. M. Hamed, P. Metcalf, and J. Kolbe, “Fixed airflow obstruction among nonsmokers with asthma: a case-comparison study,” Journal of Asthma, vol. 50, no. 6, pp. 606–612, 2013. View at Google Scholar
  28. R. Kaaks, “Nutrition, hormones, and breast cancer: is insulin the missing link?” Cancer Causes and Control, vol. 7, no. 6, pp. 605–625, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Kaaks, A. Lukanova, and M. S. Kurzer, “Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 12, pp. 1531–1543, 2002. View at Google Scholar · View at Scopus
  30. E. T. Petridou, T. N. Sergentanis, C. N. Antonopoulos et al., “Insulin resistance: an independent risk factor for lung cancer?” Metabolism: Clinical and Experimental, vol. 60, no. 8, pp. 1100–1106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. V. T. Samuel, K. F. Petersen, and G. I. Shulman, “Lipid-induced insulin resistance: unravelling the mechanism,” The Lancet, vol. 375, no. 9733, pp. 2267–2277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. N. A. Tritos and C. S. Mantzoros, “Clinical review 97: syndromes of severe insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 9, pp. 3025–3030, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. R. E. Ulane, J. E. Graeber, and R. Steinherz, “A comparison of insulin receptors in the developing fetal lung in normal and in streptozotocin-induced diabetic pregnancies,” Pediatric Pulmonology, vol. 1, no. 3, supplement, pp. S86–S90, 1985. View at Google Scholar · View at Scopus
  34. W. K. Morishige, C. A. Uetake, F. C. Greenwood, and J. Akaka, “Pulmonary insulin responsivity: in vivo effects of insulin on the diabetic rat lung and specific insulin binding to lung receptors in normal rats,” Endocrinology, vol. 100, no. 6, pp. 1710–1722, 1977. View at Google Scholar · View at Scopus
  35. N. D. Neufeld, L. M. Corbo, and S. A. Kaplan, “Plasma membrane insulin receptors in fetal rabbit lung,” Pediatric Research, vol. 15, no. 7, pp. 1058–1062, 1981. View at Google Scholar · View at Scopus
  36. F. R. Sodoyez-Goffaux, J. C. Sodoyez, and C. J. de Vos, “Insulin receptors in the fetal rat lung. A transient characteristic of fetal cells?” Pediatric Research, vol. 15, no. 9, pp. 1303–1307, 1981. View at Google Scholar · View at Scopus
  37. O. L. Miakotina, K. L. Goss, and J. M. Snyder, “Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene expression in lung epithelial cells,” Respiratory Research, vol. 3, article 27, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Dekowski and J. M. Snyder, “Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro,” Endocrinology, vol. 131, no. 2, pp. 669–676, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. M. B. Azad, A. B. Becker, and A. L. Kozyrskyj, “Association of maternal diabetes and child asthma,” Pediatric Pulmonology, vol. 48, no. 6, pp. 545–552, 2013. View at Google Scholar
  40. N. Vrachnis, N. Antonakopoulos, Z. Iliodromiti et al., “Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring,” Journal of Diabetes Research, vol. 2012, Article ID 538474, 6 pages, 2012. View at Publisher · View at Google Scholar
  41. H. Ikeda, I. Shiojima, T. Oka et al., “Increased Akt-mTOR signaling in lung epithelium is associated with respiratory distress syndrome in mice,” Molecular and Cellular Biology, vol. 31, no. 5, pp. 1054–1065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Hallman, D. Wermer, B. L. Epstein, and L. Gluck, “Effects of maternal insulin or glucose infusion on the fetus: Study on lung surfactant phospholipids, plasma myoinositol, and fetal growth in the rabbit,” American Journal of Obstetrics and Gynecology, vol. 142, no. 7, pp. 877–882, 1982. View at Google Scholar · View at Scopus
  43. R. U. Agu, M. I. Ugwoke, M. Armand, R. Kinget, and N. Verbeke, “The lung as a route for systemic delivery of therapeutic proteins and peptides,” Respiratory Research, vol. 2, no. 4, pp. 198–209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. F.-Y. Liu, D. O. Kildsig, and A. K. Mitra, “Pulmonary biotransformation of insulin in rat and rabbit,” Life Sciences, vol. 51, no. 21, pp. 1683–1689, 1992. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Shen, Q. Zhang, S. Wei, and T. Nagai, “Proteolytic enzymes as a limitation for pulmonary absorption of insulin: in vitro and in vivo investigations,” International Journal of Pharmaceutics, vol. 192, no. 2, pp. 115–121, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Ceglia, J. Lau, and A. G. Pittas, “Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus,” Annals of Internal Medicine, vol. 145, no. 9, pp. 665–675, 2006. View at Google Scholar · View at Scopus
  47. G. T. McMahon and R. A. Arky, “Inhaled insulin for diabetes mellitus,” The New England Journal of Medicine, vol. 356, no. 5, pp. 497–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Viardot, S. T. Grey, F. Mackay, and D. Chisholm, “Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype,” Endocrinology, vol. 148, no. 1, pp. 346–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Lessmann, G. Grochowy, L. Weingarten et al., “Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway,” Experimental Hematology, vol. 34, no. 11, pp. 1532–1541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. C. A. Lasagna-Reeves, A. L. Clos, T. Midoro-Hiriuti, R. M. Goldblum, G. R. Jackson, and R. Kayed, “Inhaled insulin forms toxic pulmonary amyloid aggregates,” Endocrinology, vol. 151, no. 10, pp. 4717–4724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. L. M. Hunt, M. A. Valenzuela, and J. A. Pugh, “NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance,” Diabetes Care, vol. 20, no. 3, pp. 292–298, 1997. View at Google Scholar · View at Scopus
  52. J. Lenzer, “Inhaled insulin is approved in Europe and United States,” British Medical Journal, vol. 332, no. 7537, article 321, 2006. View at Google Scholar · View at Scopus
  53. H. Shapiro, I. Kagan, M. Shalita-Chesner, J. Singer, and P. Singer, “Inhaled aerosolized insulin: a “topical” anti-inflammatory treatment for acute lung injury and respiratory distress syndrome?” Inflammation, vol. 33, no. 5, pp. 315–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. H. K. Kim, C. H. Lee, J. M. Kim, O. Ayush, S. Y. Im, and H. K. Lee, “Biphasic late airway hyperresponsiveness in a murine model of asthma,” International Archives of Allergy and Immunology, vol. 160, no. 2, pp. 173–183, 2013. View at Google Scholar
  55. S. Zuyderduyn, M. B. Sukkar, A. Fust, S. Dhaliwal, and J. K. Burgess, “Treating asthma means treating airway smooth muscle cells,” European Respiratory Journal, vol. 32, no. 2, pp. 265–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Cohen, J. P. Noveral, A. Bhala, S. E. Nunn, D. J. Herrick, and M. M. Grunstein, “Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 269, no. 2, part 1, pp. L151–L157, 1995. View at Google Scholar · View at Scopus
  57. J. P. Noveral, A. Bhala, R. L. Hintz, M. M. Grunstein, and P. Cohen, “Insulin-like growth factor axis in airway smooth muscle cells,” American Journal of Physiology, vol. 267, no. 6, part 1, pp. L761–L765, 1994. View at Google Scholar · View at Scopus
  58. M. D. Kelleher, M. K. Abe, T.-S. O. Chao et al., “Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 268, no. 6, part 1, pp. L894–L901, 1995. View at Google Scholar · View at Scopus
  59. T. L. Ediger and M. L. Toews, “Synergistic stimulation of airway smooth muscle cell mitogenesis,” Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 3, pp. 1076–1082, 2000. View at Google Scholar · View at Scopus
  60. R. Gosens, S. A. Nelemans, M. Hiemstra, M. M. Grootte Bromhaar, H. Meurs, and J. Zaagsma, “Insulin induces a hypercontractile airway smooth muscle phenotype,” European Journal of Pharmacology, vol. 481, no. 1, pp. 125–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. J. A. Hirota, T. T. B. Nguyen, D. Schaafsma, P. Sharma, and T. Tran, “Airway smooth muscle in asthma: phenotype plasticity and function,” Pulmonary Pharmacology and Therapeutics, vol. 22, no. 5, pp. 370–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Gosens, D. Schaafsma, H. Meurs, J. Zaagsma, and S. A. Nelemans, “Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype,” European Journal of Pharmacology, vol. 483, no. 1, pp. 71–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Papagianni, A. Hatziefthimiou, G. Chachami, K. Gourgoulianis, P.-A. Molyvdas, and E. Paraskeva, “Insulin causes a transient induction of proliferation via activation of the PI3-kinase pathway in airway smooth muscle cells,” Experimental and Clinical Endocrinology and Diabetes, vol. 115, no. 2, pp. 118–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Schaafsma, K. D. McNeill, G. L. Stelmack et al., “Insulin increases the expression of contractile phenotypic markers in airway smooth muscle,” American Journal of Physiology: Cell Physiology, vol. 293, no. 1, pp. C429–C439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. B. G. J. Dekkers, D. Schaafsma, T. Tran, J. Zaagsma, and H. Meurs, “Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 4, pp. 494–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Patarroyo, K. Tryggvason, and I. Virtanen, “Laminin isoforms in tumor invasion, angiogenesis and metastasis,” Seminars in Cancer Biology, vol. 12, no. 3, pp. 197–207, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Schaafsma, R. Gosens, J. M. Ris, J. Zaagsma, H. Meurs, and S. A. Nelemans, “Insulin induces airway smooth muscle contraction,” British Journal of Pharmacology, vol. 150, no. 2, pp. 136–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. K. D. Courtney, R. B. Corcoran, and J. A. Engelman, “The PI3K pathway as drug target in human cancer,” Journal of Clinical Oncology, vol. 28, no. 6, pp. 1075–1083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. A. Engelman, J. Luo, and L. C. Cantley, “The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism,” Nature Reviews Genetics, vol. 7, no. 8, pp. 606–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Uddin, A. R. Hussain, A. K. Siraj et al., “Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival,” Blood, vol. 108, no. 13, pp. 4178–4186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Jia, Z. Liu, S. Zhang et al., “Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis,” Nature, vol. 454, no. 7205, pp. 776–779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. Z. A. Knight, B. Gonzalez, M. E. Feldman et al., “A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling,” Cell, vol. 125, no. 4, pp. 733–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Numata, J. Araya, S. Fujii et al., “Insulin-dependent phosphatidylinositol 3-kinase/Akt and ERK signaling pathways inhibit TLR3-mediated human bronchial epithelial cell apoptosis,” Journal of Immunology, vol. 187, no. 1, pp. 510–519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. T. D. Clausen, E. Mathiesen, P. Ekbom, E. Hellmuth, T. Mandrup-Poulsen, and P. Damm, “Poor pregnancy outcome in women with type 2 diabetes,” Diabetes Care, vol. 28, no. 2, pp. 323–328, 2005. View at Google Scholar
  75. C. A. Crowther, J. E. Hiller, J. R. Moss, A. J. McPhee, W. S. Jeffries, and J. S. Robinson, “Effect of treatment of gestational diabetes mellitus on pregnancy outcomes,” The New England Journal of Medicine, vol. 352, no. 24, pp. 2477–2486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. D. M. Jensen, P. Damm, L. Moelsted-Pedersen et al., “Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study,” Diabetes Care, vol. 27, no. 12, pp. 2819–2823, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. J. L. Nold and M. K. Georgieff, “Infants of diabetic mothers,” Pediatric Clinics of North America, vol. 51, no. 3, pp. 619–637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. V. Compernolle, K. Brusselmans, T. Acker et al., “Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice,” Nature Medicine, vol. 8, no. 7, pp. 702–710, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. M. F. Robert, R. K. Neff, and J. P. Hubbell, “Association between maternal diabetes and the respiratory distress syndrome in the newborn,” The New England Journal of Medicine, vol. 294, no. 7, pp. 357–360, 1976. View at Google Scholar · View at Scopus
  80. E. Zmora, I. H. Gewolb, and D. L. Shapiro, “Effects of insulin and glucose on pulmonary insulin receptors in late gestation fetal rats,” Experimental Lung Research, vol. 18, no. 2, pp. 247–258, 1992. View at Google Scholar
  81. J. Aich, U. Mabalirajan, T. Ahmad, A. Agrawal, and B. Ghosh, “Loss-of-function of inositol polyphosphate-4-phosphatase reversibly increases the severity of allergic airway inflammation,” Nature Communications, vol. 3, article 877, 2012. View at Google Scholar
  82. S. J. Hirst, J. G. Martin, J. V. Bonacci et al., “Proliferative aspects of airway smooth muscle,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, supplement, pp. S2–S17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Desbois-Mouthon, A. Cadoret, M.-J. Blivet-Van Eggelpoël et al., “Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation,” Oncogene, vol. 20, no. 2, pp. 252–259, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Teng, X. Wang, Y. Wang, and D. Ma, “Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells,” Biochemical and Biophysical Research Communications, vol. 392, no. 3, pp. 373–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. S. R. Jansen, A. M. Van Ziel, H. A. Baarsma, and R. Gosens, “β-catenin regulates airway smooth muscle contraction,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 299, no. 2, pp. L204–L214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. R. Miller and R. T. Moon, “Analysis of the signaling activities of localization mutants of β- catenin during axis specification in Xenopus,” Journal of Cell Biology, vol. 139, no. 1, pp. 229–243, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. M. L. Mucenski, S. E. Wert, J. M. Nation et al., “β-catenin is required for specification of proximal/distal cell fate during lung morphogenesis,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 40231–40238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Wodarz and R. Nusse, “Mechanisms of Wnt signaling in development,” Annual Review of Cell and Developmental Biology, vol. 14, pp. 59–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. W. J. Nelson and R. Nusse, “Convergence of Wnt, β-catenin, and cadherin pathways,” Science, vol. 303, no. 5663, pp. 1483–1487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. M. L. Mucenski, J. M. Nation, A. R. Thitoff et al., “β-catenin regulates differentiation of respiratory epithelial cells in vivo,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 289, no. 6, pp. L971–L979, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. X. Zhang, J. P. Gaspard, and D. C. Chung, “Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia,” Cancer Research, vol. 61, no. 16, pp. 6050–6054, 2001. View at Google Scholar · View at Scopus
  92. S. S. Barbieri and B. B. Weksler, “Tobacco smoke cooperates with interleukin-1β to alter β-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo,” FASEB Journal, vol. 21, no. 8, pp. 1831–1843, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Bowley, D. B. O'Gorman, and B. S. Gan, “β-catenin signaling in fibroproliferative disease,” Journal of Surgical Research, vol. 138, no. 1, pp. 141–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Gosens, H. Meurs, and M. Schmidt, “The GSK-3/β-catenin-signalling axis in smooth muscle and its relationship with remodelling,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 378, no. 2, pp. 185–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh, “Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis,” Chest, vol. 123, no. 6, pp. 2007–2011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Leone, D. Courbon, F. Thomas et al., “Lung function impairment and metabolic syndrome the critical role of abdominal obesity,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 6, pp. 509–516, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Haq, A. Michael, M. Andreucci et al., “Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 8, pp. 4610–4615, 2003. View at Publisher · View at Google Scholar · View at Scopus